Review
doi: 10.1016/s0966-842x(00)88974-x.
Pseudomonas aeruginosa, mucoidy and the chronic infection phenotype in cystic fibrosis
Affiliations
- PMID: 8520888
- DOI: 10.1016/s0966-842x(00)88974-x
Item in Clipboard
Review
Pseudomonas aeruginosa, mucoidy and the chronic infection phenotype in cystic fibrosis
Trends Microbiol.
1995 Sep.
Abstract
During chronic infections in cystic fibrosis, persistence of Pseudomonas aeruginosa is associated with conversion into forms that are associated with conversion into forms that are characterized by a mucoid colony morphology, rough lipopolysaccharide and, paradoxically, decreased systemic virulence. The mutations underlying these changes occur in global regulators, such as alternative sigma factors and their accessory elements.
Similar articles
-
Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8377-81. doi: 10.1073/pnas.90.18.8377. Proc Natl Acad Sci U S A. 1993. PMID: 8378309 Free PMC article.
-
Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants.Microbiology (Reading). 2010 Apr;156(Pt 4):1108-1119. doi: 10.1099/mic.0.033993-0. Epub 2009 Dec 17. Microbiology (Reading). 2010. PMID: 20019078
-
Sigma factor-anti-sigma factor interaction in alginate synthesis: inhibition of AlgT by MucA.J Bacteriol. 1996 Aug;178(16):4990-6. doi: 10.1128/jb.178.16.4990-4996.1996. J Bacteriol. 1996. PMID: 8759865 Free PMC article.
-
Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors.J Bacteriol. 1994 May;176(10):2773-80. doi: 10.1128/jb.176.10.2773-2780.1994. J Bacteriol. 1994. PMID: 8188579 Free PMC article. Review. No abstract available.
-
Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients.Clin Microbiol Rev. 1991 Apr;4(2):191-206. doi: 10.1128/CMR.4.2.191. Clin Microbiol Rev. 1991. PMID: 1906371 Free PMC article. Review.
Cited by
-
Cystic fibrosis lung disease: genetic influences, microbial interactions, and radiological assessment.Pediatr Radiol. 2005 Aug;35(8):739-57. doi: 10.1007/s00247-005-1445-3. Epub 2005 May 3. Pediatr Radiol. 2005. PMID: 15868140 Review.
-
Immunization against Pseudomonas aeruginosa using Alg-PLGA nano-vaccine.Iran J Basic Med Sci. 2021 Apr;24(4):476-482. doi: 10.22038/ijbms.2021.52217.11813. Iran J Basic Med Sci. 2021. PMID: 34094029 Free PMC article.
-
The Small RNA ErsA Plays a Role in the Regulatory Network of Pseudomonas aeruginosa Pathogenicity in Airway Infections.mSphere. 2020 Oct 14;5(5):e00909-20. doi: 10.1128/mSphere.00909-20. mSphere. 2020. PMID: 33055260 Free PMC article.
-
Acquisition and evolution of the exoU locus in Pseudomonas aeruginosa.J Bacteriol. 2006 Jun;188(11):4037-50. doi: 10.1128/JB.02000-05. J Bacteriol. 2006. PMID: 16707695 Free PMC article.
-
Control of AlgU, a member of the sigma E-like family of stress sigma factors, by the negative regulators MucA and MucB and Pseudomonas aeruginosa conversion to mucoidy in cystic fibrosis.J Bacteriol. 1996 Aug;178(16):4997-5004. doi: 10.1128/jb.178.16.4997-5004.1996. J Bacteriol. 1996. PMID: 8759866 Free PMC article.
Publication types
MeSH terms
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
